Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
US FDA approves new nasal spray for depression treatment
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.
FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,
FDA Is Recalling This Popular Moisturizer
A popular skincare product is part of nationwide FDA recall. Do you have this moisturizer?
The U.S. Food and Drug Administration has issued a recall on a popular skin moisturizer that's available nationwide. Do you have this product?
Popular face moisturizer sold nationwide recalled, FDA says: What to know
First Aid Beauty, a popular skin care brand sold nationwide at retailers like Target, Sephora and Ulta, has issued a recall after more than 2,500 jars of its products meant for quarantine were "inadvertently distributed,
Popular face moisturizer recalled nationwide
A popular face moisturizer sold by First Aid Beauty has been recalled nationwide after some jars of the cosmetic cream that weren't meant to be sold were unintentionally distributed. The FDA has classified the recall as a Class II,
11h
Federal regulations paused, halting FDA's proposed ban on formaldehyde in hair products
Over the years, an increasing number of studies have linked formaldehyde to cancers that are especially prevalent among Black ...
STAT
2h
FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban
Following the Trump administration's DEI ban, the FDA's move to scrub webpages has ensnared many pages focused on ensuring diversity in drug trials.
8h
on MSN
FDA bans Red No. 3, but experts warn of ongoing gaps in food safety regulations
The Food and Drug Administration announced last week that it will revoke authorization for FD&C Red No. 3 in food and ingested drugs under the Delaney Clause of the Federal Food, Drug, and Cosmetic ...
2h
FDA Warns Sanofi of Manufacturing Irregularities at Key Facility
Agency cites contamination at Massachusetts plant where company makes ingredients used to produce various medicines ...
1d
on MSN
FDA warns of serious allergic reactions with some multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
2d
on MSN
FDA proposes mandatory front-of-package nutrition labels to combat spike in chronic diseases
The U.S. Food and Drug Administration (FDA) is demanding increased, in-your-face food transparency when it comes to nutrition ...
Medscape
2h
FDA Approves Grafapex (Treosulfan) for HSCT Conditioning
After a delayed approval, treosulfan’s manufacturer is hopeful the alkylating agent will become the new gold standard in the United States.
2d
FDA makes key decision on Zyn nicotine pouches
In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Trump
Food and Drug Administration
depression
nasal spray
COVID
Feedback